Tribune News Network
Doha
A state-of-the-art sterile compounding pharmacy has been opened at Hamad Medical Corporation’s (HMC) National Center for Cancer Care and Research (NCCCR). The specialised pharmacy was officially opened at the NCCCR by Ali Al Janahi, acting assistant managing director of HMC along with other dignitaries.
Sterile compounding involves preparing medications in an environment free from bacteria, viruses or any other potentially infectious microorganisms.
Sterile compounding is used for preparations that will be administered through injections, including chemotherapy, antibiotics and others.
Dr Mohammed Salem Al Hassan, CEO and medical director of NCCCR and Chairman Corporate Cancer Services at HMC, said, “This cutting-edge facility is another key part of NCCCR’s advanced treatment options, further establishing its position as a leading cancer care centre in the region,” Dr Hassan said. “The facility is also equipped with cutting-edge technologies and staffed by highly trained professionals to ensure the highest standards of safety and efficacy.”
Dr Anas Hamad, director of Pharmacy Department at NCCCR, said, “The pharmacy is designed with utmost precision and adherence to international standards, particularly the guidelines set by top regulatory bodies for chemotherapy compounding.”
